AN

Ayanka Nayak

Active Director Director DIN 09138502
DIN 09138502 First appointment Apr 2021 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Apr 2021
Shareholding value Locked Premium profile

About Ayanka Nayak

Ayanka Nayak has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Odymed Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09138502
Primary Designation Director
First Appointment 08 Apr 2021
Oldest Company Age 5 yrs

Current companies

Company Designation Appointment Founded Status
Director 08 Apr 2021 2021 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Odymed Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ayanka Nayak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ayanka Nayak

Ayanka Nayak has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Odymed Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Ayanka Nayak is associated with 1 company as Director.

Ayanka Nayak has expertise in General Business.

Ayanka Nayak has 5 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available